Switching Anti-TNF-Alpha Agents in Rheumatoid Arthritis (RA)
Public ClinicalTrials.gov record NCT00796705. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Switching Anti-TNF-alpha Agents in Patients With RA With An Inadequate Response to TNF-alpha Inhibition
Study identification
- NCT ID
- NCT00796705
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 4
- Lead sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- NIH
- Enrollment
- 13 participants
Conditions and interventions
Conditions
Interventions
- Adalimumab Drug
- Adalimumab placebo Drug
- Etanercept Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 31, 2008
- Primary completion
- Sep 30, 2010
- Completion
- Sep 30, 2010
- Last update posted
- Oct 3, 2012
2008 – 2010
United States locations
- U.S. sites
- 16
- U.S. states
- 12
- U.S. cities
- 16
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Alabama | Birmingham | Alabama | 35294 | — |
| Stanford University | Palo Alto | California | 94304 | — |
| Yale New Haven Hospital | New Haven | Connecticut | 06520 | — |
| Sarasota Arthritis Research Center | Sarasota | Florida | 34239 | — |
| Tampa Medical Group | Tampa | Florida | 33614 | — |
| University of Chicago Medical Center | Chicago | Illinois | 60637 | — |
| Justus Fiechtner, MD, PC | Lansing | Michigan | 48910 | — |
| Feinstein Institute for Medical Research NS-LIJ | Manhassett | New York | 14642 | — |
| University of Rochester | Rochester | New York | 14642 | — |
| Carolina Bone and Joint | Charlotte | North Carolina | 28210 | — |
| Duke University Medical Center | Durham | North Carolina | 27710 | — |
| Oklahoma Medical Research Foundation | Oklahoma City | Oklahoma | 73104 | — |
| Altoona Center for Clinical Research | Duncansville | Pennsylvania | 16635 | — |
| University of Pittsburgh | Pittsburgh | Pennsylvania | 15260 | — |
| Baylor Research Institute | Dallas | Texas | 75231 | — |
| University of Utah | Salt Lake City | Utah | 84132 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00796705, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 3, 2012 · Synced Jul 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00796705 live on ClinicalTrials.gov.